Half the experts pushing statins for millions more patients have cash links to drug firms: Call for inquiry into panel's connections
Six of the 12-strong panel have received thousands of pounds from manufacturers – either by being paid directly to give speeches or ‘advice’, or through funding for research. Mail.
